Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis

Rebekah A Warwick1, Craig J Ledgerwood1, Talma Brenner2

  • 1Laboratory of Experimental Surgery, Hadassah-Hebrew University Medical Center, Mount Scopus, Jerusalem 91240, Israel.

Neuroscience Letters
|April 2, 2014
PubMed

Insights

Pain in multiple sclerosis (MS) may stem from peripheral mechanisms. Satellite glial cells (SGCs) in the dorsal root ganglia show activation in a mouse model, suggesting a role in MS-associated pain.

Area of Science:

  • Neuroscience
  • Immunology
  • Pain Research

Background:

  • Multiple sclerosis (MS) frequently causes debilitating pain in patients.
  • Peripheral mechanisms contributing to MS pain remain largely unexplored.
  • Satellite glial cells (SGCs) are implicated in other neuropathic pain conditions.

Purpose of the Study:

  • To investigate the potential role of SGCs in the peripheral mechanisms of pain in multiple sclerosis.
  • To examine SGC activation in a mouse model of MS.

Main Methods:

  • Utilized a mouse model of experimental autoimmune encephalomyelitis (EAE) to mimic MS.
  • Assessed pain thresholds in EAE mice at 10 days post-induction.
  • Analyzed dorsal root ganglia for SGC activation markers and coupling.

Main Results:

  • EAE mice exhibited significantly reduced pain thresholds compared to controls.
  • Increased expression of glial fibrillary acidic protein (GFAP) was observed in SGCs, indicating activation.
  • Enhanced SGC coupling, a hallmark of activation, was detected in EAE mice.

Conclusions:

  • Findings suggest that activated SGCs contribute to peripheral pain in MS.
  • This study highlights a potential therapeutic target for managing pain in multiple sclerosis patients.